Premium
The 46C→T polymorphism in the factor XII gene ( F12 ) and the risk of venous thrombosis
Author(s) -
BERTINA R. M.,
POORT S. R.,
VOS H. L.,
ROSENDAAL F. R.
Publication year - 2005
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/j.1538-7836.2005.01198.x
Subject(s) - venous thrombosis , thrombosis , medicine , polymorphism (computer science) , factor xii , gene , immunology , genetics , allele , biology , coagulation
W, Schiffl H. Reduction of acquired high titer factor VIII antibodies by extracorporeal antibody-based immunoadsorption without additional immunosuppressive therapy. Thromb Haemost 1998; 80: 1035–6. 14 Négrier C, DechavanneM, Alfonsi F, Tremisi PJ. Successful treatment of acquired factor VIII antibody by extracorporeal immunoadsoption. Acta Haematol 1991; 85: 107–10. 15 Green D, Rademaker AW, Briet E. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of individuals with factor VIII antibodies. Thromb Haemost 1993; 70: 753–7. 16 Wiestner A, Cho HJ, Asch AS, Michelis MA, Zeller JA, Peerschke EI, Weksler BB, Schechber GP. Rituximab in the treatment of acquired factor VIII inhibitors. Blood 2002; 100: 3426– 2428. 17 Sallah S,Wan J. Efficacy of 2-CDA in refractory factor VIII inhibitors in persons without inhibitors. Blood 2003; 101: 943–5. 18 Schwartz RS, Gabriel DA, Aledort LM, Green D, Kessler CM. A Prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin. Blood 1995; 86: 797–804. 19 Hauser I, Schneider B, Leckner K. Post-partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment. Thromb Haemost 1995; 73: 1–5.